ReviewJournal of pediatric hematology/oncology2019

Advances in Anti-GD2 Immunotherapy for Treatment of High-risk Neuroblastoma.

Julie Voeller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.